ARWR

Arrowhead Pharmaceuticals, Inc.

$83.99 +3.55 (+4.41%) At close · Jul 2

Market Cap

$11.83B

140,857,021

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Past events

Date	Event	Type
2026-06-29	2026 Summer Series of R&D Webinars - Part I – Cardiometabolic	Event
2026-06-10	Goldman Sachs 47th Annual Global Healthcare Conference	Conference
2026-06-03	2026 Jefferies Global Healthcare Conference	Conference
2026-05-30	European Association for the Study of the Liver (EASL 2026) – ARO‑INHBE demonstrates clinically meaningful reductions in liver fat as monotherapy and in combination with low-dose tirzepatide in adults with obesity	Event
2026-05-27	European Atherosclerosis Society (EAS 2026) Congress	Event
2026-05-20	2026 RBC Capital Markets Global Healthcare Conference	Conference
2026-05-14	33rd European Congress on Obesity (ECO 2026) – Elevated Activin E levels correlate with insulin resistance and metabolic dysfunction in non-human primates and adult patients with obesity and type 2 diabetes	Event
2026-05-13	TIDES USA Oligonucleotide & Peptide Therapeutics – Systemic RNAi Targeting MAPT: Advancing Tau Suppression Across the CNS with TRiM™ SC	Event
2026-05-13	BofA Securities 2026 Healthcare Conference	Conference
2026-05-07	Arrowhead Pharmaceuticals 2026 Second Quarter Results	Event
2026-03-30	American College of Cardiology 75th Annual Scientific Session & Expo	Event
2026-03-09	Leerink Global Healthcare Conference	Conference
2026-03-02	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-05	Arrowhead Pharmaceuticals 2026 First Quarter Results	Event
2026-01-12	J.P. Morgan 2026 Healthcare Conference	Conference
2026-01-06	Obesity KOL Webinar - ARO-INHBE and ARO-ALK7 Interim Clinical Data	Event

Source: https://ir.arrowheadpharma.com/

Key facts CIK 879407 CUSIP 04280A100 13F (30d) 21 filings 7 filers Visit website Investor relations